Загрузка...
Depth of remission is a prognostic factor for survival in patients with metastatic renal cell carcinoma
BACKGROUND: Response remains an important endpoint in clinical cancer trials. However, the prognostic utility of best tumor response in metastatic renal cell carcinoma (mRCC) remains vague. OBJECTIVE: To define the prognostic relevance of the depth of remission in mRCC DESIGN, SETTING, AND PARTICIPA...
Сохранить в:
| Опубликовано в: : | Eur Urol |
|---|---|
| Главные авторы: | , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2015
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4570832/ https://ncbi.nlm.nih.gov/pubmed/25577718 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.eururo.2014.12.036 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|